Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

PREVALENCE OF HUMAN PAPILLOMAVIRUS IN SELF-TAKEN SAMPLES FROM SCREENING NON-ATTENDERS

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Update from a twelve-year nationwide fungaemia surveillance: increasing intrinsic and acquired resistance causes concern

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comparative Evaluation of Inoculation of Urine Samples with the Copan WASP® and BD Kiestra™ InoqulA™ Instruments

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Unexpected Diagnosis of Cerebral Toxoplasmosis by 16S and D2 Large-Subunit Ribosomal DNA PCR and Sequencing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Training non-intensivist doctors to work with COVID-19 patients in intensive care units

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The Copenhagen Self-sampling Initiative (CSi) has shown how Human Papillomavirus (HPV)-based self-sampling can be used to increase screening participation among 23,632 non-attenders in Capital Region of Denmark. Here, we described the HPV prevalence and genotype frequency in 4824 self-samples using three HPV assays (CLART, Onclarity and HC2), and compared the results to the subsequent physician-taken follow-up samples. HPV self-sample findings were also compared to a reference population of routinely screened women (N=3347, from the Horizon study), undertaken in the same screening laboratory. Non-attenders had an HPV prevalence of 11.3% based on CLART, which was lower than women from Horizon (18.5%). One-third of the CSi women who tested HPV positive by self-sampling, were HPV negative in the subsequent physician-taken follow-up sample. CLART and Onclarity agreed in 64% (95%CI: 60-68%) of the HPV positive self-samples. Adding HC2 into a three-way comparison, the agreement decreased to 27% (95% CI: 24-29%). Our findings suggest that further validation of HPV assays for self-taken samples is needed for optimal HPV detection and correct clinical management of HPV positive women.

OriginalsprogEngelsk
TidsskriftJournal of Clinical Microbiology
Vol/bind55
Udgave nummer10
Sider (fra-til)2913-2923
ISSN0095-1137
DOI
StatusUdgivet - okt. 2017

ID: 51508270